Jasmine Hamilton

Support input regarding Canada’s pharmaceutical sovereignty. Support input into the consultation on draft guidance on decentralized clinical trials. Support input into the consultation on Canada Gazette, Part I, Volume 159, Number 51: Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs. Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB. Recommend the creation of a Patient Ombudsman. Recommend the creation of a Chief Patient Officer. Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them. Provide input on the government's response to tariffs and other trade measures as they relate to pharmaceuticals and related treatments, including their ingredients, as well as other health products and devices. Also recommend providing financial relief to patients impacted by price increases. Provide input on pharmacare. Provide input on a national strategy for drugs for rare diseases. Learn more about and provide feedback on plans around COVID-19 vaccines, including protein based ones. Ensure timely access to a comprehensive range of medicines, vaccines and related treatments and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines. Ensure patient organizations are consulted and provide feedback on policies, processes, patient representation and other initiatives from Canada's Drug Agency. Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.

Enhancing cybersecurity resiliency and standards in the health sector. Improving Canada’s physical and digital infrastructure for both health research and healthcare delivery. Strengthening Canada’s health workforce including through the development of a pan-Canadian health workforce plan. Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data. Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.